GO
Loading...

Medicine

More

  • Ebola vaccine: Why it's taking so long to make one Wednesday, 1 Oct 2014 | 4:17 PM ET
    A health worker helps a doctor to fix his protective suit, on October 1, 2014 at MSF's (Doctors Without Borders) Ebola treatment center in Monrovia. Liberia.

    Efforts to develop an Ebola vaccine have been in the works for some time. But experts say it's unlikely to see one available anytime soon.

  • Oct 1- A new type of experimental cholesterol fighter being developed by Esperion Therapeutics Inc lowered LDL levels significantly more than Merck& Co Inc's Zetia in a midstage clinical trial, the company said on Wednesday.

  • Danger of Ebola spreading?     Wednesday, 1 Oct 2014 | 3:18 PM ET

    Discussing Ebola fear and the dangers of the virus spreading, with Dr. Leigh Vinocur, American College of Emergency Physicians.

  • Ebola stocks: Who's leading?     Wednesday, 1 Oct 2014 | 2:21 PM ET

    Discussing which biotech companies working on treatments for deadly viruses are the most investable, with Dr. Neil Shahrestani, Pura Vida analyst.

  • Texas DSHS confident of Ebola containment     Wednesday, 1 Oct 2014 | 2:10 PM ET

    CNBC's Meg Tirrell reports the person with the first confirmed case of Ebola in the U.S. is in serious but stable condition, and all of his contacts are being monitored.

  • Gov. Perry reassures Ebola under control     Wednesday, 1 Oct 2014 | 1:48 PM ET

    Texas Governor Rick Perry is trying to reassure people Texas will contain the spread of Ebola after one patient has been diagnosed with the disease. CNBC's Meg Tirrell reports the patient was initially released after coming in on Friday with symptoms.

  • The patient, now hospitalized in Dallas, had flown from Ebola-ravaged Liberia through Brussels to Texas, the Liberian information ministry said. JetBlue Airways and American Airlines said they were closely following guidelines from the U.S. Centers for Disease Control and Prevention.

  • Drugmaker submits harder-to-abuse Zohydro to FDA Wednesday, 1 Oct 2014 | 1:24 PM ET

    San Diego- based Zogenix said Wednesday that it submitted a Food and Drug Administration application for a new formulation of Zohydro that is designed to be more difficult to snort or inject— two common methods for abusing painkillers.

  • Dr. Schaffner: Ebola will not spread in US     Wednesday, 1 Oct 2014 | 1:08 PM ET

    Dr. William Schaffner, Vanderbilt University, explains why Ebola will not spread in the U.S.

  • Oct 1- U.S. airlines and their trade group Airlines for America are in close contact with the Centers for Disease Control and Prevention on actions the U.S. government is taking to address Ebola health concerns, according to a spokesperson for JetBlue.

  • Precaution in schools after US Ebola diagnosis     Wednesday, 1 Oct 2014 | 11:48 AM ET

    CNBC's Meg Tirrell reports provider of childcare services Bright Horizons has sent a letter to parents regarding travel to the Ebola-impacted area in West Africa.

  • Oct 1- Tekmira Pharmaceuticals Corp shares jumped as much as 25 percent on Wednesday on hopes the Canadian company could win a U.S. contract for its Ebola drug after the first case of the deadly infection was diagnosed in the United States.

  • WASHINGTON, Oct 1- Fighting the Ebola epidemic means confronting the issue of inequality, as people in poor countries have less access to knowledge and infrastructure for treating the sick and containing the deadly virus, the head of the World Bank said.

  • Oct 1- Ardelyx Inc said its experimental drug to treat constipation-related irritable bowel syndrome achieved the main goal of increasing bowel movement compared with a placebo in a mid-stage study involving 371 patients.

  • Ebola diagnosed in Texas     Wednesday, 1 Oct 2014 | 10:09 AM ET

    CNBC's Meg Tirrell reports from Dallas, Texas, where a patient has been diagnosed with Ebola. Texas state health officials say no other suspected Ebola cases are present at this time.

  • Update 1-Ardelyx bowel drug succeeds in mid-stage trial Wednesday, 1 Oct 2014 | 8:55 AM ET

    Oct 1- Ardelyx Inc said its experimental drug to treat constipation-related irritable bowel syndrome achieved the main goal of increasing bowel movement compared with a placebo in a mid-stage study involving 371 patients.

  • NEW YORK, Oct. 1- Two tiny companies are preparing to challenge some of the world's largest drug makers in the battle for dominance in the $3 billion global market for influenza vaccines, armed with little more than tiny tobacco plants.

  • Shares of companies testing Ebola vaccines rise Tuesday, 30 Sep 2014 | 6:24 PM ET

    Earlier this month NewLink Genetics said it would start safety testing of a vaccine within a few weeks, while Inovio Pharmaceuticals said it would start human trials of a DNA-based vaccine in early 2015..

  • CNBC's Meg Tirrell provides insight to comments by the CDC director about the first confirmed Ebola case in the U.S.

  • CDC's Ebola strategy     Tuesday, 30 Sep 2014 | 5:45 PM ET

    CDC Director Dr. Tom Frieden explains the CDC's investment to ensuring the spread of Ebola is stopped.